Prognostic impact of angiotensin-converting enzyme inhibitors and receptor blockers on recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator therapies
Abstract: This study sought to assess the prognostic impact of treatment with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) on recurrences of ventricular tachyarrhythmias in recipients of implantable cardioverter-defibrillators (ICD). Using a large retrospect...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2019
|
| In: |
Journal of cardiovascular pharmacology
Year: 2019, Jahrgang: 73, Heft: 5, Pages: 272-281 |
| ISSN: | 1533-4023 |
| DOI: | 10.1097/FJC.0000000000000659 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1097/FJC.0000000000000659 Verlag, Volltext: https://journals.lww.com/cardiovascularpharm/Abstract/2019/05000/Prognostic_Impact_of_Angiotensin_Converting_Enzyme.2.aspx 
|
| Verfasserangaben: | Tobias Schupp, Michael Behnes, Christel Weiß, Christoph Nienaber, Siegfried Lang, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Thomas Bertsch, Muharrem Akin, Kambis Mashayekhi, Martin Borggrefe, Ibrahim Akin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1690851201 | ||
| 003 | DE-627 | ||
| 005 | 20240404193253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200224s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/FJC.0000000000000659 |2 doi | |
| 035 | |a (DE-627)1690851201 | ||
| 035 | |a (DE-599)KXP1690851201 | ||
| 035 | |a (OCoLC)1341307917 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schupp, Tobias |d 1995- |e VerfasserIn |0 (DE-588)1168611091 |0 (DE-627)103237862X |0 (DE-576)51163840X |4 aut | |
| 245 | 1 | 0 | |a Prognostic impact of angiotensin-converting enzyme inhibitors and receptor blockers on recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator therapies |c Tobias Schupp, Michael Behnes, Christel Weiß, Christoph Nienaber, Siegfried Lang, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Thomas Bertsch, Muharrem Akin, Kambis Mashayekhi, Martin Borggrefe, Ibrahim Akin |
| 264 | 1 | |c May 2019 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.02.2020 | ||
| 520 | |a Abstract: This study sought to assess the prognostic impact of treatment with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) on recurrences of ventricular tachyarrhythmias in recipients of implantable cardioverter-defibrillators (ICD). Using a large retrospective registry including consecutive ICD recipients with documented episodes of ventricular tachycardia (VT) or fibrillation (VF) from 2002 to 2016, those patients treated with ACEi/ARB were compared with patients without. The primary prognostic endpoint was the first recurrence of ventricular tachyarrhythmias and related ICD therapies at 5 years. Multivariable Cox regression analyses were applied within the entire cohort, and thereafter, Kaplan-Meier analyses were performed in propensity-matched subgroups. A total of 592 consecutive ICD recipients were included (81% treated with ACEi/ARB and 19% without). Although ACEi/ARB was associated with no differences in overall recurrence of ventricular tachyarrhythmias, ACEi/ARB was associated with improved freedom from appropriate ICD therapy within multivariable Cox regressions (hazard ratio = 0.666; P = 0.043), especially in patients with index episodes of VF, left ventricular ejection fraction <35%, coronary artery disease, secondary preventive ICD, and glomerular filtration rate <45 mL/min/1.73 m2. In the propensity-matched subgroup, ACEi/ARB still prolonged freedom from appropriate ICD therapies (hazard ratio = 0.380; 95% confidence interval 0.193-0.747; P = 0.005). In conclusion, ACEi/ARB therapy was associated with improved freedom from appropriate ICD therapies. | ||
| 700 | 1 | |a Behnes, Michael |d 1982- |e VerfasserIn |0 (DE-588)138373361 |0 (DE-627)696560518 |0 (DE-576)307333949 |4 aut | |
| 700 | 1 | |a Weiß, Christel |d 1958- |e VerfasserIn |0 (DE-588)123287707 |0 (DE-627)082463417 |0 (DE-576)168356104 |4 aut | |
| 700 | 1 | |a Lang, Siegfried |d 1955- |e VerfasserIn |0 (DE-588)1026112613 |0 (DE-627)726109290 |0 (DE-576)371365473 |4 aut | |
| 700 | 1 | |a Akın, Ibrahim |d 1978- |e VerfasserIn |0 (DE-588)132322293 |0 (DE-627)521039010 |0 (DE-576)299074366 |4 aut | |
| 700 | 1 | |a Reiser, Linda |d 1994- |e VerfasserIn |0 (DE-588)1168611156 |0 (DE-627)1032378743 |0 (DE-576)511638981 |4 aut | |
| 700 | 1 | |a Kern-Bollow, Armin |d 1985- |e VerfasserIn |0 (DE-588)1168611180 |0 (DE-627)103237876X |0 (DE-576)511638965 |4 aut | |
| 700 | 1 | |a Taton, Gabriel |d 1985- |e VerfasserIn |0 (DE-588)1168611199 |0 (DE-627)1032378794 |0 (DE-576)511638957 |4 aut | |
| 700 | 1 | |a Reichelt, Thomas |d 1987- |e VerfasserIn |0 (DE-588)1168611245 |0 (DE-627)1032378875 |0 (DE-576)511638922 |4 aut | |
| 700 | 1 | |a Ellguth, Dominik |d 1991- |e VerfasserIn |0 (DE-588)1168611288 |0 (DE-627)103237893X |0 (DE-576)511638892 |4 aut | |
| 700 | 1 | |a Engelke, Niko |d 1992- |e VerfasserIn |0 (DE-588)1168611318 |0 (DE-627)1032378964 |0 (DE-576)511638884 |4 aut | |
| 700 | 1 | |a Borggrefe, Martin |e VerfasserIn |0 (DE-588)1025920546 |0 (DE-627)725574232 |0 (DE-576)370913426 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cardiovascular pharmacology |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1979 |g 73(2019), 5, Seite 272-281 |h Online-Ressource |w (DE-627)330612824 |w (DE-600)2049700-3 |w (DE-576)094752877 |x 1533-4023 |7 nnas |a Prognostic impact of angiotensin-converting enzyme inhibitors and receptor blockers on recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator therapies |
| 773 | 1 | 8 | |g volume:73 |g year:2019 |g number:5 |g pages:272-281 |g extent:10 |a Prognostic impact of angiotensin-converting enzyme inhibitors and receptor blockers on recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator therapies |
| 856 | 4 | 0 | |u https://doi.org/10.1097/FJC.0000000000000659 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://journals.lww.com/cardiovascularpharm/Abstract/2019/05000/Prognostic_Impact_of_Angiotensin_Converting_Enzyme.2.aspx |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200224 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 138373361 |a Behnes, Michael |m 138373361:Behnes, Michael |d 60000 |d 61000 |e 60000PB138373361 |e 61000PB138373361 |k 0/60000/ |k 1/60000/61000/ |p 2 | ||
| 998 | |g 1025920546 |a Borggrefe, Martin |m 1025920546:Borggrefe, Martin |d 60000 |d 61000 |e 60000PB1025920546 |e 61000PB1025920546 |k 0/60000/ |k 1/60000/61000/ |p 15 | ||
| 998 | |g 123287707 |a Weiß, Christel |m 123287707:Weiß, Christel |d 60000 |d 60200 |d 60250 |e 60000PW123287707 |e 60200PW123287707 |e 60250PW123287707 |k 0/60000/ |k 1/60000/60200/ |k 2/60000/60200/60250/ |p 3 | ||
| 998 | |g 1168611180 |a Kern-Bollow, Armin |m 1168611180:Kern-Bollow, Armin |d 60000 |e 60000PK1168611180 |k 0/60000/ |p 7 | ||
| 998 | |g 1168611318 |a Engelke, Niko |m 1168611318:Engelke, Niko |d 60000 |e 60000PE1168611318 |k 0/60000/ |p 11 | ||
| 998 | |g 1168611288 |a Ellguth, Dominik |m 1168611288:Ellguth, Dominik |d 60000 |d 61000 |e 60000PE1168611288 |e 61000PE1168611288 |k 0/60000/ |k 1/60000/61000/ |p 10 | ||
| 998 | |g 1168611245 |a Reichelt, Thomas |m 1168611245:Reichelt, Thomas |d 60000 |e 60000PR1168611245 |k 0/60000/ |p 9 | ||
| 998 | |g 1168611199 |a Taton, Gabriel |m 1168611199:Taton, Gabriel |d 60000 |e 60000PT1168611199 |k 0/60000/ |p 8 | ||
| 998 | |g 1026112613 |a Lang, Siegfried |m 1026112613:Lang, Siegfried |d 60000 |d 61000 |e 60000PL1026112613 |e 61000PL1026112613 |k 0/60000/ |k 1/60000/61000/ |p 5 | ||
| 998 | |g 1168611156 |a Reiser, Linda |m 1168611156:Reiser, Linda |d 60000 |e 60000PR1168611156 |k 0/60000/ |p 6 | ||
| 998 | |g 132322293 |a Akın, Ibrahim |m 132322293:Akın, Ibrahim |d 60000 |d 61000 |e 60000PA132322293 |e 61000PA132322293 |k 0/60000/ |k 1/60000/61000/ |p 16 |y j | ||
| 998 | |g 1168611091 |a Schupp, Tobias |m 1168611091:Schupp, Tobias |d 60000 |d 61000 |e 60000PS1168611091 |e 61000PS1168611091 |k 0/60000/ |k 1/60000/61000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1690851201 |e 3597703526 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1097/FJC.0000000000000659"],"eki":["1690851201"]},"recId":"1690851201","name":{"displayForm":["Tobias Schupp, Michael Behnes, Christel Weiß, Christoph Nienaber, Siegfried Lang, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Thomas Bertsch, Muharrem Akin, Kambis Mashayekhi, Martin Borggrefe, Ibrahim Akin"]},"person":[{"family":"Schupp","given":"Tobias","role":"aut","display":"Schupp, Tobias","roleDisplay":"VerfasserIn"},{"given":"Michael","family":"Behnes","role":"aut","display":"Behnes, Michael","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Weiß, Christel","family":"Weiß","given":"Christel"},{"roleDisplay":"VerfasserIn","display":"Lang, Siegfried","role":"aut","family":"Lang","given":"Siegfried"},{"roleDisplay":"VerfasserIn","display":"Akın, Ibrahim","role":"aut","family":"Akın","given":"Ibrahim"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Reiser, Linda","family":"Reiser","given":"Linda"},{"display":"Kern-Bollow, Armin","role":"aut","roleDisplay":"VerfasserIn","given":"Armin","family":"Kern-Bollow"},{"roleDisplay":"VerfasserIn","display":"Taton, Gabriel","role":"aut","given":"Gabriel","family":"Taton"},{"display":"Reichelt, Thomas","role":"aut","roleDisplay":"VerfasserIn","family":"Reichelt","given":"Thomas"},{"roleDisplay":"VerfasserIn","display":"Ellguth, Dominik","role":"aut","family":"Ellguth","given":"Dominik"},{"display":"Engelke, Niko","role":"aut","roleDisplay":"VerfasserIn","family":"Engelke","given":"Niko"},{"given":"Martin","family":"Borggrefe","role":"aut","display":"Borggrefe, Martin","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"10 S."}],"note":["Gesehen am 24.02.2020"],"language":["eng"],"title":[{"title":"Prognostic impact of angiotensin-converting enzyme inhibitors and receptor blockers on recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator therapies","title_sort":"Prognostic impact of angiotensin-converting enzyme inhibitors and receptor blockers on recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator therapies"}],"relHost":[{"recId":"330612824","id":{"issn":["1533-4023"],"zdb":["2049700-3"],"eki":["330612824"]},"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 24. November 2020"],"pubHistory":["1.1979 -"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1979","dateIssuedDisp":"1979-","publisher":"Lippincott Williams & Wilkins ; Ovid"}],"title":[{"title":"Journal of cardiovascular pharmacology","title_sort":"Journal of cardiovascular pharmacology"}],"language":["eng"],"disp":"Prognostic impact of angiotensin-converting enzyme inhibitors and receptor blockers on recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator therapiesJournal of cardiovascular pharmacology","part":{"text":"73(2019), 5, Seite 272-281","extent":"10","pages":"272-281","volume":"73","year":"2019","issue":"5"},"type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"May 2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a SCHUPPTOBIPROGNOSTIC2019 | ||